QuantRx Biomedical Corporation
QTXB · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $2 | $6 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $3 | $0 | $0 |
| Total Curr. Assets | $5 | $5 | $6 | $6 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5 | $5 | $6 | $6 |
| Liabilities | – | – | – | – |
| Payables | $16 | $14 | $14 | $10 |
| Short-Term Debt | $2,829 | $2,683 | $2,691 | $2,637 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$16 | $0 | -$14 | -$10 |
| Other Curr. Liab. | $0 | $87 | $0 | $0 |
| Total Curr. Liab. | $2,846 | $2,784 | $2,705 | $2,647 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2,846 | $25 | $2,705 | $2,647 |
| Other Liabilities | -$2,846 | -$25 | -$2,705 | -$2,647 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,846 | $2,784 | $2,705 | $2,647 |
| Equity | – | – | – | – |
| Pref Stock | $62 | $62 | $62 | $62 |
| Common Stock | $787 | $787 | $787 | $787 |
| Retained Earnings | -$52,574 | -$52,513 | -$52,433 | -$52,375 |
| AOCI | $9 | $9 | $9 | $9 |
| Other Equity | $48,876 | $48,876 | $48,876 | $48,876 |
| Total Equity | -$2,841 | -$2,779 | -$2,699 | -$2,641 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5 | $5 | $6 | $6 |
| Net Debt | $2,826 | $2,681 | $2,685 | $2,631 |